Evaluation the effect of standardized ginseng extract on blood glucose levels and lipid profile in patients with diabetes type 2.

Evaluation the effect of standardized ginseng extract Panaxs (G115 ®) on blood glucose levels, glycated hemoglobin and lipid profile in patients with diabetes type 2: double blind randomized placebo controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201103196090N1

Enrollment

Registered

2012-09-04

Start date

2012-04-08

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes type 2.

Interventions

Intervention 1: ginseng extract group will receive 300 mg of standardized ginseng extract(G115) three times a day and every time 100 mg , 30 minutes before breakfast , lunch and dinner. Intervention

Placebo

ginseng extract group will receive 300 mg of standardized ginseng extract(G115) three times a day and every time 100 mg , 30 minutes before breakfast , lunch and dinner

placebo group will receive placeb0(1g Wheat flour) three times a day and every time 100 mg , 30 minutes before breakfast , lunch and dinner

Eligibility

Sex/Gender

All

Age

40 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Fasting blood glucose greater than or equal to 126 mg/dL; At least 40 years of age; At least two years of experience of type 2 diabetes; using oral drug for controlling blood glucose (metformin, glibenclamide); No history of other diseases (such as, cardiovascular, hepatic, renal and metabolic disorders); BMI 25 to 35. Exclusion criteria: Allergies to ginseng extract; ketonuria symptoms; need for insulin.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Fasting blood glucose. Timepoint: before and after 8 weeks intervention. Method of measurement: mg/dl.;HBA1C %. Timepoint: before and after 8 weeks intervention. Method of measurement: percent of HBA1C.;Lipid profiles. Timepoint: before and after 8 weeks intervention. Method of measurement: LDL,HDL.Chol,TG,VLDL.	—

Secondary

Measure	Time frame
Blood pressure. Timepoint: once every 2 weeks. Method of measurement: Sphygmomanometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Malihi

Ahvaz Jundishapur University of Medical Sciences

r.malihi@ajums.ac.ir+98 61 1333 3050

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026